|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 3.730 USD | -4.85% |
|
-13.05% | -67.98% |
| 08-13 | ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises | MT |
| 08-13 | ARS Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.85% | -13.05% | -8.58% | -35.24% | -67.98% | -60.98% | +7.49% | - | - | 371M | |
| -3.10% | -4.19% | -12.88% | +13.49% | +56.09% | +32.67% | +59.47% | +4.36% | - | 63.48B | |
| +0.79% | +0.31% | -6.58% | +2.20% | +10.07% | +10.75% | +80.38% | +227.93% | +5,409.78% | 54.55B | |
| -0.88% | +1.19% | +8.01% | +12.64% | +17.33% | +10.66% | +102.57% | -16.84% | +234.75% | 53.59B | |
| -0.75% | +1.38% | +0.44% | +27.36% | +20.47% | +24.89% | +50.91% | +6.79% | +276.63% | 44.75B | |
| -1.30% | -4.80% | +1.44% | +12.32% | +20.49% | +16.05% | +114.76% | -0.33% | +1,015.68% | 41.62B | |
| +1.26% | -5.26% | -9.15% | -0.98% | +133.80% | +221.12% | +900.64% | +574.95% | - | 39.91B | |
| -0.74% | -4.46% | +6.31% | +5.54% | +9.41% | +11.00% | +44.65% | +4.75% | +151.07% | 32.47B | |
| +0.63% | +14.96% | +30.84% | +57.86% | +48.59% | +61.29% | +51.28% | +6.09% | +166.55% | 26.7B | |
| +3.72% | -6.23% | -13.26% | +20.06% | +47.33% | +26.01% | -8.28% | -59.79% | - | 23.36B | |
| +0.23% | -4.51% | -11.63% | -4.42% | -8.55% | -17.91% | -4.54% | -68.77% | - | 21.87B | |
| +1.75% | -0.74% | -19.41% | -9.33% | -45.44% | -42.10% | +297.65% | +259.70% | +590.12% | 20.74B | |
| -0.44% | +8.25% | +8.87% | +14.32% | +19.97% | +12.96% | +169.21% | +219.94% | +2,244.43% | 18.85B | |
| +0.44% | +13.75% | +22.54% | +59.98% | +79.89% | +83.76% | +107.91% | -16.56% | +369.19% | 17.13B | |
| +0.73% | +6.35% | +9.30% | +25.57% | +37.88% | +41.05% | +84.12% | -16.38% | +109.73% | 16.53B | |
| +0.37% | +1.49% | +12.36% | +17.09% | +49.10% | +63.42% | +223.51% | +206.81% | +498.44% | 16.19B | |
| +0.29% | +4.92% | +8.98% | -2.99% | - | - | - | - | - | 16.15B | |
| +2.59% | +3.03% | +3.03% | -0.42% | +180.86% | +161.39% | +341.90% | +1,405.54% | +779.81% | 15.21B | |
| -4.32% | -8.37% | -4.75% | -14.73% | +10.56% | +2.80% | +430.07% | - | - | 13.81B | |
| -0.44% | +5.05% | +6.18% | +8.41% | +0.42% | +0.52% | -22.24% | -35.05% | +127.36% | 14.12B | |
| Average | -0.21% | +0.54% | +1.60% | +10.44% | +32.65% | +34.70% | +159.55% | +159.01% | +921.04% | 27.57B | |
| Weighted average by Cap. | -0.23% | +0.14% | +0.26% | +12.88% | +36.94% | +39.31% | +161.11% | +126.02% | +1,224.54% |
- Stock Market
- Stocks
- SPRY Stock
- Sector ARS Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
